Diamond View II, Suite 130, 280 South Mangum Street, Durham, NC 27701

(919) 787-8880 Contact


3605 Glenwood Avenue, Suite 500, Raleigh, NC 27612

(919) 787-8880 Contact

Rob has more than 30 years’ experience in corporate and securities law. Specifically, he has dedicated the past three decades to helping entrepreneurs grow emerging technology companies in a variety of industries, including information technology, life sciences, medical devices, healthcare, nanotechnology, and advanced materials. He represents clients in a wide range of transactions including equity and debt financings, intellectual property and technology licensing, strategic alliances and partnerships, mergers and acquisitions, and general corporate matters.



For more than 30 years, Rob has dedicated his practice to serving entrepreneurs in the life science, emerging technology, information technology and advanced materials  industries, representing clients in matters involving  international and domestic equity, venture capital, debt financing, mergers and acquisitions, licensing and technology commercialization, joint ventures and strategic alliances, clinical study agreements, equity compensation, intellectual property management and strategy, and corporate governance.



  • University of Richmond School of Law – J.D. – 1989 – Cum Laude
  • University of Richmond – B.S. in Business Administration – 1984

Admitted to Practice

  • North Carolina
  • Virginia (Inactive)

Professional Activities

  • AV  Peer Rating – Martindale Hubbell
  • The Best Lawyers in America (Corporate Law), 2015 – Present
  • Chambers International (Recognized Practitioner – Corporate Law), 2018

Representative Transactions

  • Represented healthcare diagnostic company in multiple equity financings, supplier/manufacturing agreement, and Section 7874 corporate inversion.
  • Represented electric vehicle charging technology company in equity financing and Chinese joint venture.
  • Represented electron microscopy company in multiple equity financings, Delaware reincorporation, and revolving credit facility.
  • Represented advanced semiconductor materials company in multiple equity financings, Delaware reincorporation, and multiple industry joint development agreements.
  • Represented next generation 911-technology company in recapitalization and equity financing.
  • Represented pharmaceutical consulting company in transaction (change in control) incentive plan.
  • Represented pharmacogenetics company in international joint development and license agreement.
  • Represented multiple university-based technology spin-offs in a variety of intellectual property in-licensing and out-licensing transactions and research agreements.

Community Engagement

  • Board of Trustees, NC State University’s Kenan Institute for Engineering, Technology and Sciences
  • Board of Directors, University of Richmond Law School Dean’s Advisory Board

“Rob has supported us since the beginning of our company. His practical legal judgement and business acumen have been essential to the success of our firm, and his guidance has helped us avoid many pitfalls as we’ve expanded. I depend on Rob and find his work to be of extremely high quality and value.”

Reid Saleeby
Partner | Protean LLC

“Our company has benefitted from the professional guidance provided by Rob Tyler for many years.  He has supported us through several complex corporate governance issues including creating and enforcing employment agreements, establishing alternative compensation plans and, most recently, completing a recapitalization initiative.  Rob’s dedication to our success is commendable. “

Sandra W. Hallman
CPA, CFO and VP of Administration | Synergem Technologies, Inc.

“I have personally been associated with Rob Tyler for over 10 years as CEO of two early stage, investor backed, biotechnology companies.

I have depended upon Rob to provide support and guidance through the complex issues inherent with such start-ups. In addition to the legal help Rob has also shown to have an understanding as to the unique problems experienced by early stage companies allowing him to provide appropriate assistance in a cost-effective manner.

Rob has been a valuable asset to my companies with both his legal experience and business acumen and I unreservedly recommend him.”

Malcolm Thomas
CEO | Agile Sciences Inc.

Contact Us

Contact Us

Contact Us

Contact Us